(Q34548827)

3 August 2017

1 reference

title

Hemostatic and inflammatory markers as risk factors for coronary disease in the elderly (English)

1 reference

3 August 2017

Russell P Tracy

1

1 reference

3 August 2017

1 March 2002

1 reference

The American Journal of Geriatric Cardiology

3 August 2017

1 reference

3 August 2017

11

1 reference

3 August 2017

2

1 reference

3 August 2017

93-100, 107

1 reference

Inflammation markers and coronary heart disease

3 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Regulation of fibrinogen synthesis by plasmin-derived fragments of fibrinogen and fibrin: an indirect feedback pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

The putative role of fibrin fragments in the biosynthesis of fibrinogen by hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Relationship of plasmin generation to cardiovascular disease risk factors in elderly men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Serum IL-6 level and the development of disability in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Association of C-reactive protein with markers of prevalent atherosclerotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Inflammation in cardiovascular disease: cart, horse, or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

The Acute Rise in Plasma Fibrinogen Concentration With Exercise Is Influenced by the G- 453 -A Polymorphism of the β-Fibrinogen Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Sudden Cardiac Death, Genes, and Arrhythmogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

Sudden Cardiac Death, Genes, and Arrhythmogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2002.00997.X

10.1111/J.1076-7460.2002.00997.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11872967